Cel Sci (CVM) Capital Expenditures (2010 - 2025)
Cel Sci (CVM) recorded Capital Expenditures of $5,155 in fiscal Q4 2025 (quarter ended Sep 30, 2025), down 73.9% from $19,753 a year earlier.
Powered by 
Analysis
Cel Sci (CVM) Capital Expenditures (2010 - 2025) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Cel Sci reported Capital Expenditures of $38,109, down 59.8% from FY2024.
- Annual Capital Expenditures has declined for four straight fiscal years, with a five-year compound annual growth rate of -57.2% (FY2020 to FY2025).
- Across earlier fiscal years, Capital Expenditures came in at $94,875 in FY2024 (-73.8%), $361,892 in FY2023 (-43.3%), $637,892 in FY2022 (-92.9%) and $9.02 million in FY2021 (+239.6%).
- The fiscal Q4 2025 figure is the lowest quarterly Capital Expenditures since fiscal Q4 2019.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 434.5% in fiscal Q2 2021, against a decline of 99.5% in fiscal Q1 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Cel Sci | 2.74 Mn | -22.91 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 5,155.00 |
| Dec 31, 2024 | 32,954.00 |
| Sep 30, 2024 | 19,753.00 |
| Jun 30, 2024 | 23,472.00 |
| Dec 31, 2023 | 51,650.00 |
| Jun 30, 2023 | 196,860.00 |
| Mar 31, 2023 | 111,452.00 |
| Dec 31, 2022 | 53,580.00 |
| Sep 30, 2022 | 16,066.00 |
| Jun 30, 2022 | 70,965.00 |
| Mar 31, 2022 | 533,825.00 |
| Dec 31, 2021 | 17,036.00 |
| Sep 30, 2021 | 387,681.00 |
| Jun 30, 2021 | 2.00 Mn |
| Mar 31, 2021 | 3.48 Mn |
| Dec 31, 2020 | 3.15 Mn |
| Sep 30, 2020 | 1.12 Mn |
| Jun 30, 2020 | 777,530.00 |
| Mar 31, 2020 | 650,977.00 |
| Dec 31, 2019 | 101,820.00 |
API Access
Cel Sci Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();